Exploring Big Data in Hematological Malignancies: Challenges and Opportunities

被引：1
|
作者：
Westin, Gustavo F. [1 ]
Dias, Ajoy L. [1 ]
Go, Ronald S. [1 ]
机构：
[1] Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
来源：
CURRENT HEMATOLOGIC MALIGNANCY REPORTS | 2016年 / 11卷 / 04期
关键词：
Acute myeloid leukemia; Hodgkin lymphoma; Diffuse large B cell lymphoma; Multiple myeloma; Amyloidosis; Hematopoietic stem cell transplantation; CHRONIC LYMPHOCYTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; CHEMOTHERAPY PLUS RITUXIMAB; STAGE HODGKINS LYMPHOMA; ACUTE MYELOID-LEUKEMIA; HIGH-DOSE MELPHALAN; HEALTH-CARE-SYSTEM; MULTIPLE-MYELOMA; ELDERLY-PATIENTS; UNDETERMINED SIGNIFICANCE;
D O I：
10.1007/s11899-016-0331-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Secondary analysis of large datasets has become a useful alternative to address research questions outside the reach of clinical trials. It is increasingly utilized in hematology and oncology. In this review, we provided an overview of some examples of commonly used large datasets in the USA and described common research themes that can be pursued using such a methodology. We selected a sample of 14 articles on adult hematologic malignancies published in 2015 and highlighted their contributions as well as limitations.
引用
收藏
页码：271 / 279
页数：9
相关论文
共 50 条
  • [31] Bispecific Antibodies in Hematological Malignancies: A Scoping Review
    Omer, Mohamed H.
    Shafqat, Areez
    Ahmad, Omar
    Alkattan, Khaled
    Yaqinuddin, Ahmed
    Damlaj, Moussab
    CANCERS, 2023, 15 (18)
  • [32] A novel hedgehog inhibitor for the treatment of hematological malignancies
    Lin, Peng
    He, Yuanming
    Chen, Guodong
    Ma, Haikuo
    Zheng, Jiyue
    Zhang, Zubin
    Cao, Biyin
    Zhang, Hongjian
    Zhang, Xiaohu
    Mao, Xinliang
    ANTI-CANCER DRUGS, 2018, 29 (10) : 995 - 1003
  • [33] Application of vitamin D and derivatives in hematological malignancies
    Kim, Minji
    Mirandola, Leonardo
    Pandey, Apurva
    Nguyen, Diane D.
    Jenkins, Marjorie R.
    Turcel, Meryem
    Cobos, Everardo
    Chiriva-Internati, Maurizio
    CANCER LETTERS, 2012, 319 (01) : 8 - 22
  • [34] Intracranial hemorrhage in adult patients with hematological malignancies
    Chen, Chien-Yuan
    Tai, Chan-Hwei
    Cheng, Aristine
    Wu, Hung-Chang
    Tsay, Woei
    Liu, Jia-Hau
    Chen, Pey-Ying
    Huang, Shang-Yi
    Yao, Ming
    Tang, Jih-Luh
    Tien, Hwei-Fang
    BMC MEDICINE, 2012, 10
  • [35] miRNAs mediated drug resistance in hematological malignancies
    da Silva, Sara Peixoto
    Caires, Hugo R.
    Bergantim, Rui
    Guimaraes, Jose E.
    Vasconcelos, M. Helena
    SEMINARS IN CANCER BIOLOGY, 2022, 83 : 283 - 302
  • [36] Mammalian target of rapamycin as a target in hematological malignancies
    Kelly, Kevin R.
    Rowe, Julie H.
    Padmanabhan, Swaminathan
    Nawrocki, Steffan T.
    Carew, Jennifer S.
    TARGETED ONCOLOGY, 2011, 6 (01) : 53 - 61
  • [37] Bone Marrow Senescence and the Microenvironment of Hematological Malignancies
    Hellmich, Charlotte
    Moore, Jamie A.
    Bowles, Kristian M.
    Rushworth, Stuart A.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [38] Targeting nuclear import and export in hematological malignancies
    Nachmias, Boaz
    Schimmer, Aaron D.
    LEUKEMIA, 2020, 34 (11) : 2875 - 2886
  • [39] Exosomal microRNA panels as biomarkers for hematological malignancies
    Moloudizargari, Milad
    Hekmatirad, Shirin
    Mofarahe, Zahra Shams
    Asghari, Mohammad Hossein
    CURRENT PROBLEMS IN CANCER, 2021, 45 (05)
  • [40] Combination Therapy with Arsenic Trioxide for Hematological Malignancies
    Takahashi, Shinichiro
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2010, 10 (06) : 504 - 510
12345